Jommi C, Cipriani F, Fanelli F, Pedone MP, Canonica W. The effects of disease cross-coverage by dupilumab on the costs sustained by the Italian National Health Service. Grhta [Internet]. 2020 Jul. 14 [cited 2024 Nov. 21];7(1):33-9. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/2139